Federated Hermes’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-65
| Closed | -$1.3K | – | 2300 |
|
2022
Q4 | $1.3K | Sell |
65
-7
| -10% | -$140 | ﹤0.01% | 2039 |
|
2022
Q3 | $1K | Buy |
72
+39
| +118% | +$542 | ﹤0.01% | 2107 |
|
2022
Q2 | $1K | Buy |
33
+10
| +43% | +$303 | ﹤0.01% | 2111 |
|
2022
Q1 | $1K | Buy |
+23
| New | +$1K | ﹤0.01% | 2141 |
|
2018
Q3 | – | Sell |
-1,054
| Closed | -$2.26M | – | 2349 |
|
2018
Q2 | $2.26M | Buy |
1,054
+427
| +68% | +$915K | 0.01% | 956 |
|
2018
Q1 | $1.56M | Buy |
+627
| New | +$1.56M | ﹤0.01% | 1061 |
|